You are here:  news items - Androgel™

AndroGel™, from UNIMED PHARMACEUTICALS, is the first-ever testosterone replacement gel to be approved by the FDA for replacement therapy in men for conditions associated with low testosterone. Low testosterone, also known as hypogonadism, affects approximately four to five million American men. The condition is linked with diminished interest in sex, impotence, reduced lean body mass, decreased bone density and lowered mood and energy levels. AndroGel™ will be available with a prescription in pharmacies throughout the United States by mid-summer.